Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $43.8 Million - $60.5 Million
-1,801,873 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $47 Million - $72.8 Million
1,801,873 New
1,801,873 $60.8 Million
Q4 2020

Feb 16, 2021

SELL
$39.09 - $57.4 $69.2 Million - $102 Million
-1,771,101 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$28.43 - $44.67 $50.4 Million - $79.1 Million
1,771,101 New
1,771,101 $76.8 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Light Street Capital Management, LLC Portfolio

Follow Light Street Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Light Street Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Light Street Capital Management, LLC with notifications on news.